H Fensterer

664 total citations
9 papers, 462 citations indexed

About

H Fensterer is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, H Fensterer has authored 9 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in H Fensterer's work include Pancreatic and Hepatic Oncology Research (3 papers), TGF-β signaling in diseases (3 papers) and Gastroesophageal reflux and treatments (2 papers). H Fensterer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), TGF-β signaling in diseases (3 papers) and Gastroesophageal reflux and treatments (2 papers). H Fensterer collaborates with scholars based in Germany, Italy and France. H Fensterer's co-authors include Thomas M. Gress, Guido Adler, Patrick Michl, Gerhard Leder, Malte Buchholz, Klaudia Giehl, Cláudia Barth, Markus M. Lerch, André Menke and Matthias Löhr and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Annals of Oncology.

In The Last Decade

H Fensterer

9 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Fensterer Germany	7	205	195	155	136	108	9	462
Erik T. Goka United States	7	31 0.2×	288 1.5×	67 0.4×	77 0.6×	115 1.1×	10	421
Matthew Ashenden United Kingdom	4	19 0.1×	224 1.1×	87 0.6×	182 1.3×	54 0.5×	4	369
Hun-Taek Kim United States	5	21 0.1×	162 0.8×	129 0.8×	112 0.8×	15 0.1×	6	340
Xun Sun China	14	13 0.1×	303 1.6×	123 0.8×	140 1.0×	43 0.4×	31	456
Seon Yong Lee South Korea	10	25 0.1×	188 1.0×	101 0.7×	89 0.7×	21 0.2×	15	346
Hai Yu China	16	19 0.1×	565 2.9×	162 1.0×	446 3.3×	31 0.3×	31	792
Qin Niu China	13	15 0.1×	381 2.0×	145 0.9×	265 1.9×	33 0.3×	17	565
A. C. Diserens Switzerland	8	29 0.1×	201 1.0×	186 1.2×	69 0.5×	22 0.2×	9	517
Leslie A. Caromile United States	11	11 0.1×	163 0.8×	73 0.5×	65 0.5×	29 0.3×	16	358
Frederick D. Park United States	5	11 0.1×	227 1.2×	82 0.5×	50 0.4×	38 0.4×	5	349

Countries citing papers authored by H Fensterer

Since Specialization

Citations

This map shows the geographic impact of H Fensterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Fensterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Fensterer more than expected).

Fields of papers citing papers by H Fensterer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Fensterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Fensterer. The network helps show where H Fensterer may publish in the future.

Co-authorship network of co-authors of H Fensterer

This figure shows the co-authorship network connecting the top 25 collaborators of H Fensterer. A scholar is included among the top collaborators of H Fensterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Fensterer. H Fensterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Fensterer, H, Carmen Schade‐Brittinger, Hans‐Helge Müller, et al.. (2013). Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP). Annals of Oncology. 24(10). 2576–2581. 28 indexed citations

Fensterer, H, Carmen Schade‐Brittinger, Hans‐Helge Mueller, et al.. (2011). Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). 4039–4039. 2 indexed citations

Kunsch, Steffen, Albrecht Neeße, T Linhart, et al.. (2009). Impact of Pantoprazole on Duodeno-Gastro-Esophageal Reflux (DGER). Zeitschrift für Gastroenterologie. 47(3). 277–282. 6 indexed citations

Kunsch, Steffen, T Linhart, H Fensterer, et al.. (2008). Prävalenz eines pathologischen Duodeno-Gastro-Ösophagealen Refluxes (DGER) bei Patienten mit klinischen Beschwerden einer Refluxerkrankung. Zeitschrift für Gastroenterologie. 46(5). 409–414. 2 indexed citations

Fensterer, H, Bernhard Radlwimmer, Jörn Sträter, et al.. (2007). Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks. BMC Cancer. 7(1). 58–58. 13 indexed citations

Fensterer, H, Klaudia Giehl, Malte Buchholz, et al.. (2004). Expression profiling of the influence of RAS mutants on the TGFB1‐induced phenotype of the pancreatic cancer cell line PANC‐1. Genes Chromosomes and Cancer. 39(3). 224–235. 29 indexed citations

Michl, Patrick, Cláudia Barth, Malte Buchholz, et al.. (2003). Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.. PubMed. 63(19). 6265–71. 258 indexed citations

Buchholz, Malte, Wolfgang Boeck, H Fensterer, et al.. (2001). Use of DNA arrays/microarrays in pancreatic research. Pancreatology. 1(6). 581–586. 12 indexed citations

Weber, Christoph K., Patrick Michl, H Fensterer, et al.. (2001). Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology. 121(3). 657–667. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact